News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,195 Results
Type
Article (120)
Company Profile (1)
Press Release (3077)
Section
Business (743)
Career Advice (2)
Deals (114)
Drug Development (402)
FDA (77)
Job Trends (73)
News (1232)
Policy (94)
Tag
Academia (7)
Allergies (1)
Alliances (238)
Alzheimer's disease (12)
Approvals (82)
Artificial intelligence (7)
ASCO (1)
Automation (1)
Bankruptcy (1)
Best Places to Work (63)
Biologics (1)
Biosimilars (6)
Biotechnology (1)
Cancer (27)
Cardiovascular disease (2)
Career advice (2)
CAR-T (5)
CDMO (1)
Cell therapy (5)
Clinical research (366)
Collaboration (15)
Compensation (8)
COVID-19 (22)
CRISPR (1)
C-suite (6)
Data (86)
Depression (2)
Dermatology (2)
Diabetes (5)
Diagnostics (64)
Drug discovery (2)
Earnings (306)
Events (476)
FDA (115)
Funding (7)
Gene editing (1)
Gene therapy (31)
GLP-1 (10)
Government (8)
Guidances (2)
Healthcare (56)
Immunology and inflammation (1)
Indications (2)
Infectious disease (22)
Inflammatory bowel disease (1)
IPO (53)
Job creations (14)
Job search strategy (2)
Layoffs (2)
Legal (15)
Liver cancer (1)
Lung cancer (13)
Lymphoma (2)
Machine learning (2)
Manufacturing (7)
Medical device (43)
Medtech (49)
Mergers & acquisitions (74)
Metabolic disorders (5)
mRNA (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (26)
NextGen: Class of 2026 (22)
Non-profit (13)
Obesity (1)
Opinion (1)
Ovarian cancer (2)
Pain (5)
Parkinson's disease (11)
Partnered (1)
Patient recruitment (5)
People (143)
Peptides (1)
Phase 1 (136)
Phase 2 (203)
Phase 3 (111)
Pipeline (129)
Postmarket research (3)
Preclinical (49)
Radiopharmaceuticals (1)
Rare diseases (3)
Real estate (28)
Regulatory (122)
Research institute (11)
Resumes & cover letters (1)
RNA editing (2)
Series A (2)
Series B (1)
Sponsored (1)
Startups (10)
Supply chain (2)
Vaccines (6)
Date
Last 7 days (12)
Last 30 days (31)
Last 365 days (223)
2026 (184)
2025 (172)
2024 (211)
2023 (195)
2022 (266)
2021 (245)
2020 (219)
2019 (201)
2018 (167)
2017 (169)
2016 (146)
2015 (163)
2014 (89)
2013 (88)
2012 (89)
2011 (105)
2010 (97)
Location
Africa (2)
Alabama (1)
Asia (133)
Australia (32)
California (42)
Canada (19)
China (7)
Colorado (4)
Europe (440)
Florida (4)
Georgia (24)
Illinois (8)
Indiana (4)
Japan (4)
Kentucky (1)
Maryland (5)
Massachusetts (35)
Michigan (5)
Missouri (5)
Nevada (23)
New Hampshire (5)
New Jersey (16)
New York (23)
North Carolina (110)
Northern California (26)
Ohio (1)
Oregon (1)
Pennsylvania (27)
South America (2)
Southern California (9)
Texas (20)
United States (341)
Virginia (1)
Washington State (1)
Wyoming (1)
3,195 Results for "mogene lc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Median Technologies’ eyonis® LCS Obtains CE Marking
July 3, 2026
·
9 min read
Press Releases
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
September 15, 2026
·
14 min read
Press Releases
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
September 14, 2026
·
7 min read
Press Releases
BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
August 31, 2026
·
7 min read
Press Releases
Median Technologies Reports Record iCRO Backlog, Accelerates Commercial Rollout of eyonis® LCS and Development of New Indications Across the eyonis® Portfolio
July 23, 2026
·
9 min read
Press Releases
Median Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer Screening
July 30, 2026
·
8 min read
Press Releases
BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
May 26, 2026
·
7 min read
Press Releases
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples
March 11, 2026
·
2 min read
Press Releases
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage
February 17, 2026
·
4 min read
Press Releases
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
February 12, 2026
·
8 min read
1 of 320
Next
